December « 2010 « ACTC.OB investor blog

These are the posts from December 2010

December 13, 2010
Posted by admin

The Economist Magazine covers ACT’s programs; Proactive Investors conducts video interview with ACT Chairman & CEO

“I used to think. Now, I just read The Economist.”
- Larry Ellison, CEO, Oracle Corp. (Nasdaq: ORCL)
“The magazine I spend most of my days reading is The Economist.”
- Bill Gates, Chairman, Microsoft Corporation (Nasdaq: MSFT)
“[The Economist] magazine is probably read by more presidents, prime ministers, and chief executives around the world than any other.”
- [...]

1 Comment

Posted Under Uncategorized

December 7, 2010
Posted by admin

FT Magazine on ACT’s FDA Approval: “Could early stem cell trials cure blindness?”; As Positive International Media Coverage Continues

Enthusiasm about ACT’s recent FDA approval for the first clinical trial using human embryonic stem cells to treat macular degeneration continues unabated. Over the weekend, FT Magazine, published by the Financial Times, features ACT in a piece titled “Could early stem cell trials cure blindness?”
In the piece, FT’s Science Editor Clive Cookson writes, “After [...]

No Comments

Posted Under Uncategorized

December 1, 2010
Posted by admin

Blinded by the Light: Eye-Popping Amount of Positive Media Coverage of ACT’s FDA Approval

ACT’s announcement last Monday, November 22nd that it has received approval to start a Phase I/II Human Clinical Trial using human embryonic stem cells to treat eye disease has been greeted with a cacophony of enthusiastic media coverage from around the world.
From the scientific outlets such as Nature and Scientific American to business wires such [...]

3 Comments

Posted Under Uncategorized

ACT's Company Blog.

Advanced Cell Technology, Inc. (OTCBB: ACTC) is a biotechnology company applying cellular technology in the field of regenerative medicine. For more information, visit www.advancedcell.com.

These are the posts from December 2010

The Economist Magazine covers ACT’s programs; Proactive Investors conducts video interview with ACT Chairman & CEO

FT Magazine on ACT’s FDA Approval: “Could early stem cell trials cure blindness?”; As Positive International Media Coverage Continues

Blinded by the Light: Eye-Popping Amount of Positive Media Coverage of ACT’s FDA Approval

ACTC.OB Stock Quote

Categories

Archives

Facebook

ACT Links